News Room
Technophage was recognized with ‘PME líder 2023’ distinction by IAPMEI
We are thrilled to announce that Technophage has been recognized by IAPMEI, I.P. - Agência para a Competitividade e Inovação (Agency for...
Technophage honored with a Healthcare & Pharmaceutical Award
For eight years in a row, the Healthcare & Pharmaceutical Awards have recognized the pioneers transforming our healthcare field. We are thrilled...
TZ-161 one step closer to clinical trials in spinal cord injury
Technophage is thrilled to share that TZ-161 product is now one step closer to potentially becoming a pioneering repurposed treatment for patients...
Pipeline
Invest in our products
GMP manufacturing
Learn more about GMP manufacturing
Technophage
Who we are, What we do
Therapeutic
areas
TechnoPhage is committed to the development of biological and chemical products for infection, neurosciences and ophthalmology